3D Static Strength Prediction Program
The 3D Static Strength Prediction Program™ (3D SSPP) is an effective way to analyze the biomechanics and safety of manual materials handling. The software allows the user to predict static strength requirements for common manual tasks like lifts, presses, pushes, and pulls.
(1990)
Aastrom
Developing autologous stem cell products for use in regenerative medicine
(1989)
BioQuant
Discovering and developing drugs for oncology, inflammation, immunology, & metabolic diseases
(1987)
TSRL, Inc.
Developing drug delivery solutions
(1987)
Cartox
In vitro cardiotoxicity testing platform using mature human stem cell derived cardiomyocytes
Endectra
Endectra LLC is commercializing solid-state, real-time radiation detection technology to displace expensive crystal- and gas-based sensors in defense, industrial, and medical applications.
ExoDynamics
Smart, active spinal orthoses that provides support and mobility to users
MEKanistic Therapeutics
MEKanistic is innovating cancer therapies by advancing a novel class of selective kinase inhibitors rationally designed to target both EGFR and PI3K with a single molecule. This breakthrough design expands the therapeutic window while avoiding inherent toxicity challenges of multi-compound treatments. Preclinical studies of its lead drug MTX-531 show a high incidence of tumor regression with dramatically reduced toxicity.
